Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Exercise	Group	Sex	Type
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	337299	Peak area normalized	Yes	Borderline Pressures	Male	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	482305	Peak area normalized	Yes	PAH	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	517398	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	610414	Peak area normalized	Yes	Borderline Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	686981	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	718447	Peak area normalized	Yes	Healthy	Male	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	748260	Peak area normalized	No	Borderline Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	771210	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	868874	Peak area normalized	Yes	Normal Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	891557	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	912927	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	932710	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	964349	Peak area normalized	Yes	PAH	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	991026	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1041766	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1053284	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1144723	Peak area normalized	Yes	PAH	Male	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1169166	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1171296	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1173848	Peak area normalized	Yes	Healthy	Male	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1196840	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1201823	Peak area normalized	No	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1218394	Peak area normalized	No	Borderline Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1228148	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1243666	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1282035	Peak area normalized	Yes	Borderline Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1311617	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1321010	Peak area normalized	No	PAH	Male	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1329191	Peak area normalized	No	PAH	Male	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1334899	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1347202	Peak area normalized	No	Healthy	Male	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1348282	Peak area normalized	No	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1352525	Peak area normalized	Yes	Normal Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1358416	Peak area normalized	No	Borderline Pressures	Male	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1360408	Peak area normalized	Yes	LowRisk	Male	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1361545	Peak area normalized	No	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1367657	Peak area normalized	No	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1377598	Peak area normalized	No	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1392208	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1392916	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1407341	Peak area normalized	No	LowRisk	Male	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1409519	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1414498	Peak area normalized	No	PAH	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1416208	Peak area normalized	Yes	PAH	Male	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1440834	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1451307	Peak area normalized	Yes	PAH	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1458137	Peak area normalized	Yes	Normal Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1462666	Peak area normalized	No	Borderline Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1464688	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1479385	Peak area normalized	Yes	PAH	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1484593	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1492954	Peak area normalized	No	Borderline Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1493828	Peak area normalized	Yes	Borderline Pressures	Male	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1498787	Peak area normalized	Yes	Borderline Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1512312	Peak area normalized	Yes	Normal Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1536568	Peak area normalized	No	PAH	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1542285	Peak area normalized	No	Borderline Pressures	Male	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1546366	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1551866	Peak area normalized	No	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1561410	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1573613	Peak area normalized	Yes	Healthy	Male	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1581398	Peak area normalized	No	Borderline Pressures	Male	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1588196	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1589357	Peak area normalized	No	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1591022	Peak area normalized	Yes	Borderline Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1596842	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1597434	Peak area normalized	Yes	Borderline Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1601020	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1602727	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1613211	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1631141	Peak area normalized	Yes	PAH	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1634982	Peak area normalized	No	PAH	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1645869	Peak area normalized	No	Healthy	Male	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1670074	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1672205	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1717848	Peak area normalized	Yes	Borderline Pressures	Male	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1765140	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1769353	Peak area normalized	No	Normal Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1798445	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1801168	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1813711	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1845296	Peak area normalized	No	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1851894	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1888502	Peak area normalized	No	Normal Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1917648	Peak area normalized	No	PAH	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1934983	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	1942810	Peak area normalized	Yes	Borderline Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	2012774	Peak area normalized	Yes	PAH	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	2013280	Peak area normalized	No	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	2019407	Peak area normalized	Yes	Borderline Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	2058571	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	2091178	Peak area normalized	No	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	2102624	Peak area normalized	No	PAH	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	2156565	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	2162282	Peak area normalized	No	Normal Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	2299180	Peak area normalized	No	PAH	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	2351340	Peak area normalized	No	Borderline Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	2451072	Peak area normalized	No	PAH	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-	2483097	Peak area normalized	No	Borderline Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	No	Borderline Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	No	Healthy	Male	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	No	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	No	LowRisk	Male	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	No	Normal Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	No	Normal Pressures	Male	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	No	PAH	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	No	PAH	Male	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	Yes	Borderline Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	Yes	Healthy	Male	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	Yes	LowRisk	Male	Non-invasive
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	Yes	Normal Pressures	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	Yes	Normal Pressures	Male	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	Yes	PAH	Female	Cath
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (M-H)-		Peak area normalized	Yes	PAH	Male	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	24619	Peak area normalized	Yes	PAH	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	26282	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	28796	Peak area normalized	Yes	Borderline Pressures	Male	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	30833	Peak area normalized	No	Borderline Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	37305	Peak area normalized	Yes	Borderline Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	38567	Peak area normalized	No	Normal Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	41045	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	41916	Peak area normalized	No	LowRisk	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	45003	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	48392	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	50950	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	52463	Peak area normalized	No	Borderline Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	53015	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	53925	Peak area normalized	Yes	Healthy	Male	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	55129	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	55862	Peak area normalized	Yes	Normal Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	56727	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	57519	Peak area normalized	Yes	PAH	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	59115	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	60081	Peak area normalized	Yes	Normal Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	60317	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	62791	Peak area normalized	Yes	Borderline Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	62889	Peak area normalized	Yes	Borderline Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	62973	Peak area normalized	No	Healthy	Male	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	64101	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	67756	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	67964	Peak area normalized	No	Normal Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	68065	Peak area normalized	Yes	PAH	Male	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	68328	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	69674	Peak area normalized	Yes	PAH	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	70019	Peak area normalized	Yes	Borderline Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	71675	Peak area normalized	Yes	Normal Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	72829	Peak area normalized	Yes	Normal Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	73382	Peak area normalized	No	PAH	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	74313	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	76327	Peak area normalized	No	PAH	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	76726	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	78145	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	80655	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	81022	Peak area normalized	Yes	PAH	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	81316	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	82259	Peak area normalized	Yes	LowRisk	Male	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	82628	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	82732	Peak area normalized	No	Borderline Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	82781	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	82906	Peak area normalized	Yes	PAH	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	83420	Peak area normalized	No	Borderline Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	83747	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	87064	Peak area normalized	No	PAH	Male	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	87573	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	88387	Peak area normalized	No	Normal Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	88751	Peak area normalized	No	LowRisk	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	90688	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	91150	Peak area normalized	No	PAH	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	91202	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	91498	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	91793	Peak area normalized	Yes	Healthy	Male	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	93678	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	93907	Peak area normalized	No	LowRisk	Male	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	94262	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	96042	Peak area normalized	Yes	Normal Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	96179	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	96593	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	97843	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	98130	Peak area normalized	Yes	Normal Pressures	Male	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	98381	Peak area normalized	Yes	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	98879	Peak area normalized	No	Borderline Pressures	Male	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	99372	Peak area normalized	No	Borderline Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	99416	Peak area normalized	No	Borderline Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	99675	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	99914	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	100558	Peak area normalized	No	Healthy	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	101214	Peak area normalized	Yes	Normal Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	101800	Peak area normalized	Yes	Borderline Pressures	Female	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	102166	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	102207	Peak area normalized	No	LowRisk	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	102253	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	102446	Peak area normalized	No	LowRisk	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	102714	Peak area normalized	Yes	Borderline Pressures	Male	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	102981	Peak area normalized	Yes	Borderline Pressures	Male	Cath
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	103380	Peak area normalized	Yes	LowRisk	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	103491	Peak area normalized	No	LowRisk	Female	Non-invasive
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (M+H)+	103627	Peak area normalized	No	Normal Pressures	Female	Cath

Return to search page